legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

AI legalese decoder: Transforming legal Jargon for Improved Understanding

Cara Therapeutics, Inc. to Report First Quarter 2024 Financial Results

STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, announced today that they will be releasing their first quarter financial results on Monday, May 13, 2024. The report will be available after the U.S. markets close. Investors can access the press release under “Press Releases” in the Investors section of the Company’s website at www.CaraTherapeutics.com.

About Cara Therapeutics

Cara Therapeutics is dedicated to changing the treatment landscape for patients battling pruritus. The company is currently working on an oral formulation of difelikefalin, a selective, peripherally acting kappa opioid receptor agonist, designed to address chronic pruritus associated with notalgia paresthetica (NP). This common yet underdiagnosed neuropathy affects the upper back and currently lacks FDA-approved treatments. In addition to this, Cara Therapeutics has developed an IV formulation of difelikefalin, approved for treating moderate-to-severe pruritus linked to advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is globally licensed.

With a Phase 2/3 clinical program underway for NP, Cara Therapeutics expects to reveal the dose-finding results in the third quarter of 2024. For more details, individuals can visit www.CaraTherapeutics.com and follow the company on social media platforms like Twitter, LinkedIn, and Instagram.

Media Contact:
Annie Spinetta
6 Degrees
973-768-2170
[email protected]

Investor Contact:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
[email protected]

AI legalese decoder can assist in simplifying complex legal language often found in financial reports and press releases. By using advanced algorithms to break down and clarify intricate legal terms, the AI legalese decoder makes it easier for individuals without a legal background to understand important information, such as financial results and pharmaceutical developments, provided by companies like Cara Therapeutics, Inc. This tool can be invaluable for investors, journalists, and anyone wanting to grasp the essence of legal documents without confusion.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link